Class information for:
Level 1: VISCERAL LEISHMANIASIS//CUTANEOUS LEISHMANIASIS//LEISHMANIASIS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
159 4046 29.1 69%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
697 12289 VISCERAL LEISHMANIASIS//CUTANEOUS LEISHMANIASIS//LEISHMANIASIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 VISCERAL LEISHMANIASIS Author keyword 219 38% 11% 465
2 CUTANEOUS LEISHMANIASIS Author keyword 156 40% 8% 304
3 LEISHMANIASIS Author keyword 111 23% 10% 419
4 KALA AZAR Author keyword 94 50% 3% 136
5 MEGLUMINE ANTIMONIATE Author keyword 75 73% 1% 57
6 SODIUM STIBOGLUCONATE Author keyword 62 75% 1% 45
7 PENTAVALENT ANTIMONIALS Author keyword 53 95% 0% 18
8 KALA AZAR MED Address 52 80% 1% 32
9 MILTEFOSINE Author keyword 44 42% 2% 80
10 POST KALA AZAR DERMAL LEISHMANIASIS Author keyword 42 71% 1% 34

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 VISCERAL LEISHMANIASIS 219 38% 11% 465 Search VISCERAL+LEISHMANIASIS Search VISCERAL+LEISHMANIASIS
2 CUTANEOUS LEISHMANIASIS 156 40% 8% 304 Search CUTANEOUS+LEISHMANIASIS Search CUTANEOUS+LEISHMANIASIS
3 LEISHMANIASIS 111 23% 10% 419 Search LEISHMANIASIS Search LEISHMANIASIS
4 KALA AZAR 94 50% 3% 136 Search KALA+AZAR Search KALA+AZAR
5 MEGLUMINE ANTIMONIATE 75 73% 1% 57 Search MEGLUMINE+ANTIMONIATE Search MEGLUMINE+ANTIMONIATE
6 SODIUM STIBOGLUCONATE 62 75% 1% 45 Search SODIUM+STIBOGLUCONATE Search SODIUM+STIBOGLUCONATE
7 PENTAVALENT ANTIMONIALS 53 95% 0% 18 Search PENTAVALENT+ANTIMONIALS Search PENTAVALENT+ANTIMONIALS
8 MILTEFOSINE 44 42% 2% 80 Search MILTEFOSINE Search MILTEFOSINE
9 POST KALA AZAR DERMAL LEISHMANIASIS 42 71% 1% 34 Search POST+KALA+AZAR+DERMAL+LEISHMANIASIS Search POST+KALA+AZAR+DERMAL+LEISHMANIASIS
10 ANTIMONY RESISTANCE 35 86% 0% 18 Search ANTIMONY+RESISTANCE Search ANTIMONY+RESISTANCE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 KALA AZAR 436 54% 14% 566
2 SODIUM STIBOGLUCONATE 353 68% 8% 309
3 VISCERAL LEISHMANIASIS 239 25% 21% 844
4 DIRECT AGGLUTINATION TEST 175 65% 4% 165
5 SODIUM STIBOGLUCONATE PENTOSTAM 152 89% 2% 70
6 PENTAVALENT ANTIMONY 148 66% 3% 136
7 MEGLUMINE ANTIMONIATE 112 59% 3% 127
8 INDIAN VISCERAL LEISHMANIASIS 97 63% 2% 97
9 MUCOCUTANEOUS LEISHMANIASIS 93 55% 3% 116
10 ORAL MILTEFOSINE 92 68% 2% 81

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Leishmaniasis: an update of current pharmacotherapy 2013 44 76 99%
The relationship between leishmaniasis and AIDS: the second 10 years 2008 279 216 77%
Drug resistance in leishmaniasis 2006 572 142 69%
Leishmaniasis in immunosuppressed individuals 2014 17 155 83%
Visceral leishmaniasis: What are the needs for diagnosis, treatment and control? 2007 395 143 76%
Leishmaniasis chemotherapy-challenges and opportunities 2011 106 43 88%
Advances in leishmaniasis 2005 722 175 53%
Mucosal leishmaniasis with primary oral involvement: a case series and a review of the literature 2015 2 18 83%
LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014 2014 10 122 97%
Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years 1997 493 147 84%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 KALA AZAR MED 52 80% 0.8% 32
2 KALAAZAR MED 18 89% 0.2% 8
3 RAJENDRA MEM MED SCI 15 45% 0.6% 25
4 UNIT MOL PARASITOL 8 41% 0.4% 16
5 LEISHMANIASIS 8 31% 0.5% 22
6 PL TOXINOL ANTIPARASIT DRUGS 6 80% 0.1% 4
7 PESQUISAS CLIN 6 24% 0.6% 23
8 EPIDEMIOL CLIN SCI 6 100% 0.1% 4
9 TROP MED INFECTOL 6 100% 0.1% 4
10 WHO ABORATING LEISHMANIASIS 5 32% 0.3% 14

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000177059 CANINE VISCERAL LEISHMANIASIS//LEISHMANIA INFANTUM//CANINE LEISHMANIASIS
2 0.0000175500 PHLEBOTOMINAE//SAND FLIES//LUTZOMYIA LONGIPALPIS
3 0.0000148149 LEISHMANIA//LEISHMANIA MAJOR//LEISHMANIASIS
4 0.0000090471 LIPOPHOSPHOGLYCAN//LEISHMANIA//GP63
5 0.0000066931 METACASPASE//DYSKINETOPLASTIDY//APOPTOSIS LIKE PROGRAMMED CELL DEATH
6 0.0000066430 SCHISTOSOMAL NEPHROPATHY//CLIN NEPHROL UNITE HEMODIALYSE//HELMINTHOL ROMERO LASCASAS PORTO MICROBI
7 0.0000058425 DINITROANILINES//DINITROANILINE//DRUG EFFICACY IN VIVO
8 0.0000057201 HEPATOPROTECTIVE PROPERTY//ACALYPHA RACEMOSA//ANTIOXIDANT TRACE ELEMENTS
9 0.0000034273 HETEROCYCLIC BETAINES//4 NITROBENZIMIDAZOLE DERIVATIVE//HETERORETINOID
10 0.0000033148 AMPHOTERICIN B//AMPHOTERICIN B LIPID COMPLEX//AMPHOTERICIN B COLLOIDAL DISPERSION